Evidence map›Paper›PMID 28368496›Full record

ArticleThe Journal of infectious diseases2017

Characterization of Human Cytomegalovirus Genome Diversity in Immunocompromised Hosts by Whole-Genome Sequencing Directly From Clinical Specimens.

Elias Hage, Gavin S Wilkie, Silvia Linnenweber-Held, Akshay Dhingra, Nicolás M Suárez, Julius J Schmidt, Penelope C Kay-Fedorov, Eva Mischak-Weissinger, Albert Heim, Anke Schwarz and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Elias HageInstitute of Virology.
Gavin S WilkieMRC-University of Glasgow Centre for Virus Research, United Kingdom.
Silvia Linnenweber-HeldDepartment of Nephrology.
Akshay DhingraInstitute of Virology.
Nicolás M SuárezMRC-University of Glasgow Centre for Virus Research, United Kingdom.
Julius J SchmidtDepartment of Nephrology.
Penelope C Kay-FedorovInstitute of Virology.
Eva Mischak-WeissingerDepartment of Haematology, Haemostasis and Oncology, Hannover Medical School.
Albert HeimInstitute of Virology.
Anke SchwarzDepartment of Nephrology.
Thomas F SchulzInstitute of Virology.
Andrew J DavisonMRC-University of Glasgow Centre for Virus Research, United Kingdom.
Tina GanzenmuellerInstitute of Virology.

Funding

Medical Research Council MC_UU_12014/12Medical Research Council MC_UU_12014/3
6 · The paper itself

Abstract

Background: Advances in next-generation sequencing (NGS) technologies allow comprehensive studies of genetic diversity over the entire genome of human cytomegalovirus (HCMV), a significant pathogen for immunocompromised individuals. Methods: Next-generation sequencing was performed on target enriched sequence libraries prepared directly from a variety of clinical specimens (blood, urine, breast milk, respiratory samples, biopsies, and vitreous humor) obtained longitudinally or from different anatomical compartments from 20 HCMV-infected patients (renal transplant recipients, stem cell transplant recipients, and congenitally infected children). Results: De novo-assembled HCMV genome sequences were obtained for 57 of 68 sequenced samples. Analysis of longitudinal or compartmental HCMV diversity revealed various patterns: no major differences were detected among longitudinal, intraindividual blood samples from 9 of 15 patients and in most of the patients with compartmental samples, whereas a switch of the major HCMV population was observed in 6 individuals with sequential blood samples and upon compartmental analysis of 1 patient with HCMV retinitis. Variant analysis revealed additional aspects of minor virus population dynamics and antiviral-resistance mutations. Conclusions: In immunosuppressed patients, HCMV can remain relatively stable or undergo drastic genomic changes that are suggestive of the emergence of minor resident strains or de novo infection.

Indexed as

Immunocompromised HostAdultAgedCohort StudiesCytomegalovirusCytomegalovirus InfectionsDNA, ViralDrug Resistance, ViralFemaleGenetic VariationGenome, ViralGenomicsHigh-Throughput Nucleotide SequencingHumansInfantInfant, NewbornDNA, Viralbloodevolutiongenome diversityhuman cytomegalovirus (HCMV)immunocompromisednext-generation sequencingstrain switch

Identifiers

PMID28368496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.